Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cánceres Gastrointestinal / Cáncer del Ano / Recursos de NCI
National Cancer Institute®
Ultima Vez Modificado: 1 de septiembre del 2002
1
UI - 11255344
AU - Knispel J; Shaw JC
TI -
Nonhealing perianal ulcer.
SO - Arch Dermatol 2001 Mar;137(3):365-70
AD - University of Chicago Hospitals, Chicago, IL, USA.
2
UI - 12063923
AU - Dolanc R; Kocher T; Langer I; Marti WR; Pierer G; Harder F
TI -
[Malignant transformation of perianal Buschke-Lowenstein tumor.
Extensive abdominoperineal rectum excision and reconstruction with
transpelvic myocutaneous rectus abdominis muscle flap]
SO - Chirurg 2002 Apr;73(4):370-4
AD - Departement Chirurgie, Kantonsspital, 4600 Olten, Schweiz.
rdolanc_ol@spital.ktso.ch
INTRODUCTION: The Buschke Lowenstein tumor (giant condyloma) in its
perianal variant is an extremely rare disease caused by human papilloma
virus. Although of histologically benign appearance, it infiltrates and
destroys the surrounding tissue. There is a high risk of local
recurrence and malignant transformation. The treatment of choice is wide
surgical resection. CASE: A 56-year-old woman presented with perianal
giant condyloma infiltrating the rectum and vagina. The extensive soft
tissue defect resulting from wide resection was filled with a
transpelvic myocutaneous rectus abdominis flap. Histology showed a
squamous cell carcinoma arising in the Buschke Lowenstein tumor with
clear resection margins. Therefore, the patient was irradiated locally
after uneventful primary wound healing. CONCLUSION: A simultaneous
reconstruction of a large pelvinoperineal soft tissue defect with the
transpelvic myocutaneous rectus abdominis flap allows primary healing,
accelerated rehabilitation, and safe adjuvant radiotherapy without risk
of serious radiation damage to the small bowel by preventing it from
protruding into the pelvic defect.
3
UI - 12168920
AU - Scala M; Bonelli G; Gipponi M; Margarino G; Muzza A
TI -
Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated
lesions.
SO - Anticancer Res 2002 Mar-Apr;22(2B):1171-6
AD - Department of Surgical Oncology, Istituto Nazionale per la Ricerca sul
Cancro, Genoa, Italy.
OBJECTIVE: The authors report their experience in patients with adjuvant
systemic 2-interferon with the aim of defining the effectiveness,
side-effects, indications and limitations of this treatment. MATERIALS
genital, anorectal and perineal HPV lesions were treated with
cryosurgery; adjuvant systemic a2-interferon was administered to 38 of
them. There were 76 female and 47 male patients (median age of 29 years,
range; 15-56 years). Clinical examinations included: digital rectal
examination, head and neck examination, urethral meatus inspection and,
in female patients, gynaecological examination; they underwent
colposcopylurethroscopy, proctosigmoidoscopy, cystoscopy (in advanced
disease); scraping for cytology and PCR analysis, and biopsy for
histology. Twenty-three percent of patients had more than one site
involved; upper digestive tract involvement was observed in 6.6% and 47%
had lesions larger than 6 sqcm. Twenty-five females with genital lesions
had esocervical lesions only; ten of them had SIL1, while seven a SIL3.
RESULTS: Ninety-eight out of 123 patients (79.7%) were recurrence-free
after a median follow-up of 32 months. A recurrence was observed in 25
patients: in univariate analysis, recurrence of disease occurred more
frequently in females (p = 0.04), in patients with longer duration of
symptoms (p = 0.0002),with wider lesions (p = 0.00015), with head and
neck involvement (p < 0.01), and in HIV-positive patients (p = 0.03). In
multivariate analysis, duration of symptoms (p = 0.005), head and neck
involvement (p = 0.01), and width of lesion > 3 sq cm (p = 0.025) were
associated with increased risk CONCLUSION: Our findings confirm the
value of cryosurgery in the treatment HPV lesions; it is less traumatic,
and gives good aesthetic and functional results; moreover, large lesions
may be treated and the depth of cryonecrosis is more suitably adapted.
Patients amenable to adjuvant treatment with a2-interferon should have
multiorgan involvement, HPV type 16 or 18, lesions >3 sqcm, long lasting
symptoms (>6 months) and presence of SIL.
4
UI - 1321267
AU - Iftner T; Oft M; Bohm S; Wilczynski SP; Pfister H
TI -
Transcription of the E6 and E7 genes of human papillomavirus type 6 in
anogenital condylomata is restricted to undifferentiated cell layers of
the epithelium.
SO - J Virol 1992 Aug;66(8):4639-46
AD - Institut fur Klinische und Molekulare Virologie, Friedrich Alexander
Universitat Erlangen-Nurnberg, Germany.
The E6 and E7 genes of human genital papillomaviruses (HPVs) appear to
transform cells by different mechanisms. They seem to act
synergistically but are not equally important when tested under diverse
experimental conditions. We were therefore tempted to investigate the
E6- and E7-specific transcription pattern in HPV6-infected condylomas
separately, by in situ hybridization. Recent studies have identified
three promoters within the E6-E7 region of HPV6 and HPV11 by applying
S1, exonuclease VII, and cDNA analyses. On the basis of these data, we
cloned subgenomic fragments of HPV6 into plasmid pBS to obtain
riboprobes that differentiated between transcripts starting upstream of
the E6 and E7 open reading frames, respectively. These different species
of mRNAs were analyzed in serial thin sections of eight HPV6-positive
anogenital condylomas. The E6 probe (nucleotides 7862 to 241) led to
weak signals within the basal layer. In three cases, rather strong
signals were confined to a few basal cells. The E7 probe (nucleotides
242 to 534) gave rise to a more pronounced labeling of all cells within
the two to three lowest epidermal layers. In situ hybridization with a
riboprobe for human c-fos revealed an expression pattern similar to that
observed with the E7 probe. In contrast to the preferential expression
of the transforming E6 and E7 genes in the lower epithelium, the major
transcriptional activity of the virus was detected in the middle and
upper third by probes colinear with the 3' moiety of the early region.
5
UI - 12073068
AU - Zbar AP; Fenger C; Efron J; Beer-Gabel M; Wexner SD
TI -
The pathology and molecular biology of anal intraepithelial neoplasia:
comparisons with cervical and vulvar intraepithelial carcinoma.
SO - Int J Colorectal Dis 2002 Jul;17(4):203-15
AD - Department of Colorectal Surgery, Kaplan Medical Center, Rehovot,
Israel. apzbar@zahav.net.il
BACKGROUND: Anal intraepithelial neoplasia (AIN) is a well-described
pathological precursor of invasive squamous cell carcinoma which has
recently been detected with increasing frequency in immunocompromised
patients, particularly those with seropositivity for human
immunodeficiency virus (HIV). The epidemiology and natural history of
this entity is somewhat unclear, since the overall prevalence in the HIV
seronegative population is unknown. DISCUSSION: There is a clear
etiological association between AIN and high-risk human papillomavirus
(HPV) subtype infection although there is great variability in HPV DNA
detection of cytological and histological material in these patients. It
appears that there is an antigen-specific hyporesponsiveness by
cytotoxic lymphocytes against HPV peptide sequences or recombinant
proteins encoded by oncogenic HPV subtypes in these patients, which is
dependent upon the stage of their HIV-associated disease. Although the
molecular biology of AIN and cervical or vulvar intraepithelial
neoplasia are comparable, in AIN there is less significance of tumor
suppressor gene mutations, proto-oncogenic growth factor activation, and
genomic instability. CONCLUSION: Current concepts in the epidemiology
and etiology of AIN are discussed, as well as its immunological response
in the HIV-positive population, drawing parallels where possible between
other HPV-related preinvasive disorders, and concluding with a suggested
management protocol
6
UI - 12109222
AU - Schmidbauer S; Sitzmann G; Trupka A; Hallfeldt KK
TI -
[Laparoscopic colostomy: experience in patients with ovarian or
ano-rectal cancer, non-operable or with rectovaginal fistula]
SO - G Chir 2002 Mar;23(3):101-3
AD - Chirurgische Klinik und Poliklinik, Klinikum Innestadt
Ludwig-Maximilians Universitaet Muenchen.
carried out in 23 patients with advanced ovarian cancer, inoperable
carcinoma of the anorectum or rectovaginal fistulas. There were no
intraoperative or postoperative complications and postoperative recovery
was rapid with all patients having function of the colostomy within 24
hrs and regaining their preoperative state of mobility on the second
postoperative day. The laparoscopic approach allows the careful
selection of the colostomy site, easy mobilisation of the colon, causing
only little disruption to the intestinal function hence improving
postoperative recovery. From Authors' experience, laparoscopic colostomy
is a simple and safe operation in most cases and can be used as the
preferred technique of intestinal diversion.
7
UI - 12195200
AU - Botterill ID; Sagar PM
TI -
Adenocarcinoma in the residual outflow tract after incomplete excision
of a failed ileoanal pouch: a late complication of unrecognized Crohn's
colitis: report of a case.
SO - Dis Colon Rectum 2002 Aug;45(8):1112-5
AD - Department of Colorectal Surgery, The General Infirmary, Leeds, United
Kingdom.
A case of adenocarcinoma complicating the outflow tract remnant of a
previously excised ileoanal pouch is described. The pouch had failed
because of unsuspected Crohn's disease. This is the first reported case
of malignancy complicating a pouch that had been constructed in a
patient with Crohn's disease. More importantly, it demonstrates that
carcinoma may develop in the outflow tract remnant left in situ after
simple pouch excision. This case suggests that patients who require
pouch excision may benefit from excision of the outflow tract.
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Ms. Schafer discusses the role of the chaplain and spirituality in cancer care. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

